ArticleClinical genitourinary cancer2021

Small Cell Bladder Cancer Response to Second-line and Beyond Checkpoint Inhibitor Therapy: Retrospective Experience.

Jean Hoffman-Censits et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.